Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

Fe65L Activators

Fe65L Activators represent a group of chemical compounds that can enhance the activity of Fe65L through various signaling pathways and biological processes. Forskolin, 8-Bromo-cAMP, and Dibutyryl-cAMP (db-cAMP) are compounds that increase intracellular cAMP levels, leading to the activation of PKA. The activated PKA can phosphorylate and enhance the activity of Fe65L by targeting proteins within its signaling network. Ionomycin, through its action as a calcium ionophore, may also enhance Fe65L's activity by raising intracellular calcium levels, subsequently activating calmodulin-dependent kinases that could phosphorylate Fe65L-associated proteins.

Other compounds like PMA and Insulin trigger different pathways-PKC, EGFR, and PI3K/Akt, respectively-each influencing the phosphorylation state and activity of Fe65L. Calyculin A and Okadaic Acid act as phosphatase inhibitors, which can lead to a sustained phosphorylated state of proteins that associate with Fe65L, enhancing its functional activity. In contrast, U73122 and Staurosporine influence secondary messenger levels and kinase activity, respectively, which could indirectly enhance the activity of Fe65L by altering the signaling landscape in which it operates. Anisomycin, by activating SAPKs, can also enhance the function of Fe65L through stress response pathways.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$78.00
$153.00
$740.00
$1413.00
$2091.00
73
(3)

Forskolin activates adenylyl cyclase, increasing cAMP levels, which leads to PKA activation. PKA can phosphorylate various proteins that may be part of Fe65L's signaling network, thereby enhancing its activity.

Ionomycin

56092-82-1sc-3592
sc-3592A
1 mg
5 mg
$78.00
$270.00
80
(4)

Ionomycin raises intracellular calcium levels, which can activate calmodulin-dependent kinases that may phosphorylate proteins interacting with Fe65L, enhancing its activity.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

PMA activates PKC, which phosphorylates proteins that could be involved in Fe65L's activity, potentially enhancing its function.

Insulin

11061-68-0sc-29062
sc-29062A
sc-29062B
100 mg
1 g
10 g
$156.00
$1248.00
$12508.00
82
(1)

Insulin engages the PI3K/Akt pathway, potentially enhancing Fe65L's activity by affecting the phosphorylation state of its interacting partners.

8-Bromoadenosine 3′,5′-cyclic monophosphate

23583-48-4sc-217493B
sc-217493
sc-217493A
sc-217493C
sc-217493D
25 mg
50 mg
100 mg
250 mg
500 mg
$108.00
$169.00
$295.00
$561.00
$835.00
2
(1)

8-Bromo-cAMP, a cAMP analog, activates PKA, which can phosphorylate proteins within Fe65L's network and enhance its functional activity.

Calyculin A

101932-71-2sc-24000
sc-24000A
10 µg
100 µg
$163.00
$800.00
59
(3)

Calyculin A inhibits serine/threonine phosphatases, potentially enhancing Fe65L's activity by maintaining the phosphorylation state of associated proteins.

Okadaic Acid

78111-17-8sc-3513
sc-3513A
sc-3513B
25 µg
100 µg
1 mg
$291.00
$530.00
$1800.00
78
(4)

Okadaic Acid, a phosphatase inhibitor, could enhance Fe65L's function by increasing the phosphorylation levels of proteins within its signaling network.

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$153.00
$396.00
113
(4)

At low concentrations, Staurosporine selectively inhibits certain kinases, potentially enhancing Fe65L's activity by modifying the phosphorylation state of its network proteins.

Anisomycin

22862-76-6sc-3524
sc-3524A
5 mg
50 mg
$99.00
$259.00
36
(2)

Anisomycin activates stress-activated protein kinases (SAPKs), which could enhance Fe65L's activity by altering the function of interacting proteins.

Dibutyryl-cAMP

16980-89-5sc-201567
sc-201567A
sc-201567B
sc-201567C
20 mg
100 mg
500 mg
10 g
$47.00
$136.00
$492.00
$4552.00
74
(7)

db-cAMP is a cAMP analog that activates PKA, potentially enhancing the function of Fe65L through the phosphorylation of proteins in its signaling network.